Canopy Growth Corp (TSE:WEED – Get Free Report) shares hit a new 52-week low during trading on Wednesday. The stock traded as low as C$1.03 and last traded at C$1.04, with a volume of 555,289 shares trading hands. The stock had previously closed at C$1.08.
Wall Street Analysts Forecast Growth
Separately, Alliance Global Partners reduced their target price on Canopy Growth from C$1.80 to C$1.60 in a report on Tuesday, June 16th. Two investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of C$1.88.
View Our Latest Report on Canopy Growth
Canopy Growth Stock Down 5.6%
Canopy Growth (TSE:WEED – Get Free Report) last posted its earnings results on Friday, August 7th. The company reported C($0.03) EPS for the quarter. The company had revenue of C$81.17 million during the quarter. Canopy Growth had a negative return on equity of 29.85% and a negative net margin of 73.95%. On average, analysts predict that Canopy Growth Corp will post -0.69 EPS for the current year.
Insider Activity at Canopy Growth
In related news, Director David Angelo Lazzarato sold 22,380 shares of Canopy Growth stock in a transaction on Monday, September 28th. The stock was sold at an average price of C$1.29, for a total value of C$28,870.20. Following the completion of the sale, the director owned 108,237 shares of the company’s stock, valued at C$139,625.73. The trade was a 17.13% decrease in their ownership of the stock. Insiders sold a total of 43,492 shares of company stock valued at $56,105 over the last three months. Insiders own 0.21% of the company’s stock.
About Canopy Growth
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands.
Recommended Stories
- Five stocks we like better than Canopy Growth
- Tesla Wants to Make Its Own Chips—What Could Go Wrong?
- IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver?
- PBF Energy’s Stunning Rally Faces a Critical Test
- Citi Stock Falls Despite Earnings Beat: What Investors Need to Know
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.
